{"id":"W3157994245","doi":"10.1136/annrheumdis-2020-219601","title":"Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Tofacitinib; Medicine; Placebo; Ankylosing spondylitis; Adverse effect; Internal medicine; Randomized controlled trial; Janus kinase inhibitor; Gastroenterology; Surgery; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002293596,0.0002583467,0.001236086,0.00005384061,0.0002585897,0.00002734209,0.0001320265,0.00003180809,0.0003037899],"category_scores_gemma":[0.0003973152,0.0001290221,0.001011254,0.0002039931,0.0001447137,0.00005144763,0.00004476306,0.00003358469,0.000001893983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002506437,"about_ca_system_score_gemma":0.0001775539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001091779,"about_ca_topic_score_gemma":0.00003722024,"domain_scores_codex":[0.9981965,0.0001300424,0.0007516846,0.0002559218,0.0003801354,0.0002857107],"domain_scores_gemma":[0.9971663,0.001307738,0.0003881111,0.0006798977,0.0003458588,0.0001120618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.88936,0.02749381,0.003465569,0.0003465227,0.01401624,0.00007377376,0.003800713,0.00003625778,0.0000470776,0.0002792393,0.000958794,0.06012204],"study_design_scores_gemma":[0.9783813,0.00302369,0.001969283,0.000713907,0.005280951,0.00002096856,0.006298267,0.0001850874,0.002663525,0.0003091948,0.001012939,0.0001408625],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9673849,0.02224229,0.00003067368,0.001266895,0.0001953451,0.007787679,0.0008495722,0.00001918533,0.0002233968],"genre_scores_gemma":[0.9943197,0.002706996,0.00004325209,0.0001154037,0.00004897284,0.001917945,0.00008391413,0.00002282377,0.0007409849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08902136,"threshold_uncertainty_score":0.5261367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09127472958911044,"score_gpt":0.3844357516029048,"score_spread":0.2931610220137943,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}